
| Pair Name | Amentoflavone, Cisplatin | ||
| Phytochemical Name | Amentoflavone (PubChem CID: 5281600 ) | ||
| Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Amentoflavone, Cisplatin | |||
| Disease Info | [ICD-11: 2B66.0] | Oral squamous cell carcinoma | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Down-regulation | Activity | RELA | hsa5970 |
| Up-regulation | Expression | BAX | hsa581 | |
| Up-regulation | Cleavage | CASP9 | hsa842 | |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Up-regulation | Expression | BAK1 | hsa578 | |
| Down-regulation | Activity | NFKB1 | hsa4790 | |
| In Vitro Model | SAS | Tongue squamous cell carcinoma | Homo sapiens (Human) | CVCL_1675 |
| Result | Inactivation of NF-κB and induction of apoptosis through intrinsic caspase-dependent and independent apoptotic pathways are associated with amentoflavone enhanced anti-OSCC efficacy of cisplatin. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin. Anticancer Res. 2020 Dec;40(12):6723-6732. doi: 10.21873/anticanres.14695. | Click |